Craig Henke is a Respiratory physician affiliated with University of Minnesota. OpenAlex indexes 88 publications with 5,529 citations (h-index 39).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
University Of Minnesota Physicians
516 Delaware Street SE, Pwb Second Floor, Clinic 2a
Minneapolis, MN 55455
Telephone
612-626-6100Registry record last updated 26 Oct 2012.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Apria Healthcare LLCProgram year20211 payment
- Insmed, Inc.Program year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2022)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
54.2%Kinase inhibitor46.5%Ofev100%Part D<11 patientsPyridone7.7%Esbriet100%Part D<11 patientsAnti-infectives
26.8%Macrolide Antimicrobial14.8%Azithromycin100%Part D<11 patientsShort-acting sulfonamides12%Sulfamethoxazole-Trimethoprim100%Part D<11 patientsMetabolism & gastrointestinal
19%Corticosteroid19%Prednisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
10 NIH research awards on record, funded 1989–2022 per NIH RePORTER. The latest:
- S100A4 Regulation of IPF Mesenchymal Progenitor Cell Fibrogenicity
University of Minnesota
FY2022$522,986R01HL146501 - S100A4 Regulation of IPF Mesenchymal Progenitor Cell Fibrogenicity
University of Minnesota
FY2021$592,286R01HL146501 - Summer Research at the University of Minnesota Medical School
University of Minnesota
FY2021$186,620R25HL088728
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- IL-8 concurrently promotes idiopathic pulmonary fibrosis mesenchymal progenitor cell senescence and PD-L1 expression enabling escape from immune cell surveillance
American Journal of Physiology-Lung Cellular and Molecular Physiology
2023 - Hyaluronan/CD44 axis regulates S100A4-mediated mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis
American Journal of Physiology-Lung Cellular and Molecular Physiology
2021
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Blazar, MD
University of Minnesota
Jay Cohn, MD
University of Minnesota
Julia Steinberger, MD
University of Minnesota
Charles Herzog, MD
University of Minnesota
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”